Authors/Disclosures
|
Andrew D. Campbell, PhD
|
No disclosure on file |
|
Robert P. Rubens, MD, MBA, FAAN, FAAN
(NeuroDevMA Consulting, Inc.)
|
Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals. |
|
Jacob George, MD
(GOVT: MEDICAL COLLEGE , KOTTAYAM)
|
No disclosure on file |
|
Thomas C. Wessel, MD
|
No disclosure on file |
|
Kathleen Bowler, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Andrew Krystal, MD
|
No disclosure on file |
|
James Walsh, PhD
(Sleep Medicine and Research Center)
|
No disclosure on file |
|
Thomas Roth, PhD
(Henry Ford Hospital)
|
Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Roth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. |
|
|
No disclosure on file |